RecruitingNot ApplicableNCT06391086

Neuromodulation Effect of Focused Ultrasound for Motor Recovery in Patients With Stroke


Sponsor

National Taiwan University Hospital

Enrollment

20 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Transcranial focused ultrasound (tFUS) can be used as a non-invasive brain neuromodulation technique. Low-intensity focused ultrasound has been demonstrated to be safe and have neuromodulatory effects on the cerebral cortex in healthy human and animal experiments.This study aims to investigate the effect of tFUS on cortical excitability for motor recovery in patients with stroke.


Eligibility

Min Age: 18 Years

Inclusion Criteria6

  • Patients with stroke (including hemorrhagic or ischemic stroke) diagnosed by a board-certificated physician.
  • Occurrence of stroke within three months.
  • Upper limb muscle strength ≤ 4 points according to the Medical Research Council Manual Muscle Testing scale.
  • No previous history of stroke, epilepsy, dementia, Parkinson's disease, or other neurodegenerative diseases.
  • Patients could maintain sitting posture for more than 15 minutes on a chair.
  • years of age or older.

Exclusion Criteria16

  • History of recurrent stroke, traumatic brain injuries, brain tumors, spinal cord injury, Parkinson's disease or other musculoskeletal system diseases that may affect evaluation and treatment.
  • Contraindications to focused ultrasound, including pregnancy, cardiac pacemaker or implantable medical device, abnormal connective tissue diseases, coagulopathy (PLT\<100,000/μL, PT\>14 seconds, APTT\>36 seconds, INR\>1.3), implants near or in the brain, or those deemed Unsuitable for this treatment by the physician.
  • Unable to cooperate with treatment or functional assessment due to impaired consciousness or aphasia; inability to informed consent.
  • Patient with cranial bone factor causing the inability of tFUS penetration.
  • Patient under anticoagulants with coagulopathy (PLT\<100,000/μL, PT\>14 seconds, APTT\>36 seconds, INR\>1.3)
  • Patients who are not suitable for undergoing CT imaging examination;
  • Major physical illnesses and neurological disorders (such as epilepsy, brain surgery, etc.)
  • Patients with metallic implants in their bodies;
  • Patients taking tricyclic antidepressants, analgesics, or using antiepileptic drugs
  • Individuals experiencing sleep disorders during tFUS treatment;
  • Individuals with history of alcoholism
  • Patients with severe or uncontrollable intracranial pressure;
  • Patients requiring anticoagulants;
  • Any intracranial space-occupying lesions;
  • Significant calcification of intracranial vessels based on pre-treatment CT imaging;
  • Subjects with lesions/wounds on the scalp in the target region.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENaviFUS® Neuronavigation-guided focused ultrasound system

The treatment protocol consists of once daily treatment for consecutive five tFUS sessions.


Locations(1)

National Taiwan University Hospital

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06391086


Related Trials